Glucosamine & Chondoitin
Natural health product licensed in Canada
- Licence holder
- Thorne Research, Inc.
- NPN or DIN-HM
- 80003034
- Status
- Active licence
- Licence date
- 19 March 2007
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Hypromellose, L-leucine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Glucosamine sulphate helps to relieve osteoarthritic pain and is a factor in the building of healthy cartilage. Glucosamine sulphate also protects against the deterioration of cartilage from chronic joint disease and is effective in reducing joint pain. Chondroitin sulphate helps to relieve symptoms of bone and joint pain, and helps the formation of connective tissue. Use for a minimum of 2 months to see beneficial effects. For prolonged use, consult a health care practitioner.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist. Consult a health care practitioner if you experience gastrointestinal pain or bowel movement disturbances.
- Contre-indications
Do not use if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80003034
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.